{
    "id": 4166,
    "fullName": "CTNNB1 S37F",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "CTNNB1 S37F lies within the ubiquitination recognition motif of the Ctnnb1 protein and occurs at a Gsk3b phosphorylation site on the Ctnnb1 protein (PMID: 10347231). S37F is predicted to confer a gain of function to the Ctnnb1 protein as demonstrated by nuclear accumulation of Ctnnb1 (PMID: 11196159, PMID: 11943721) and increased cell invasion and migration in the context of an EGFR activating mutation (PMID: 29106415).",
            "references": [
                {
                    "id": 2339,
                    "pubMedId": 11196159,
                    "title": "More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11196159"
                },
                {
                    "id": 10426,
                    "pubMedId": 29106415,
                    "title": "Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29106415"
                },
                {
                    "id": 2336,
                    "pubMedId": 10347231,
                    "title": "The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10347231"
                },
                {
                    "id": 2340,
                    "pubMedId": 11943721,
                    "title": "Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11943721"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1499,
        "geneSymbol": "CTNNB1",
        "terms": [
            "CTNNB1",
            "armadillo",
            "CTNNB",
            "EVR7",
            "MRD19",
            "NEDSDV"
        ]
    },
    "variant": "S37F",
    "createDate": "03/28/2015",
    "updateDate": "12/13/2017",
    "referenceTranscriptCoordinates": {
        "id": 138058,
        "transcript": "NM_001098210",
        "gDna": "chr3:g.41224622C>T",
        "cDna": "c.110C>T",
        "protein": "p.S37F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20746,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a retrospective analysis, activating CTNNB1 mutations including S37F/C (n=5), D32V (n=1), G34V (n=1), and T41I (n=1) were identified in 8 of 100 patients with non-small cell lung cancer at treatment discontinuation of Tagrisso (osimertinib) (PMID: 31839416).",
            "molecularProfile": {
                "id": 3974,
                "profileName": "CTNNB1 S37F"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 18023,
                    "pubMedId": 31839416,
                    "title": "Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31839416"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19912,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with an advanced solid tumor developed resistance to treatment with Tagrisso (osimertinib) and was found via cell free DNA testing to harbor CCDC6-RET and CTNNB1 S37F (PMID: 31300450).",
            "molecularProfile": {
                "id": 34668,
                "profileName": "CCDC6 - RET CTNNB1 S37F"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17588,
                    "pubMedId": 31300450,
                    "title": "Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31300450"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3974,
            "profileName": "CTNNB1 S37F",
            "profileTreatmentApproaches": [
                {
                    "id": 8047,
                    "name": "PDPK1 Inhibitor",
                    "profileName": "CTNNB1 S37F"
                },
                {
                    "id": 8046,
                    "name": "Tankyrase Inhibitor",
                    "profileName": "CTNNB1 S37F"
                },
                {
                    "id": 8045,
                    "name": "CTNNB1 Inhibitor",
                    "profileName": "CTNNB1 S37F"
                }
            ]
        },
        {
            "id": 34668,
            "profileName": "CCDC6 - RET CTNNB1 S37F",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 138057,
            "transcript": "NM_001098209",
            "gDna": "chr3:g.41224622C>T",
            "cDna": "c.110C>T",
            "protein": "p.S37F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 138060,
            "transcript": "XM_005264886",
            "gDna": "chr3:g.41224622C>T",
            "cDna": "c.110C>T",
            "protein": "p.S37F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 138058,
            "transcript": "NM_001098210",
            "gDna": "chr3:g.41224622C>T",
            "cDna": "c.110C>T",
            "protein": "p.S37F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 138061,
            "transcript": "XM_017005738",
            "gDna": "chr3:g.41224622C>T",
            "cDna": "c.110C>T",
            "protein": "p.S37F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 138056,
            "transcript": "NM_001904",
            "gDna": "chr3:g.41224622C>T",
            "cDna": "c.110C>T",
            "protein": "p.S37F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 138059,
            "transcript": "XM_006712985",
            "gDna": "chr3:g.41224622C>T",
            "cDna": "c.110C>T",
            "protein": "p.S37F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}